Skip to main content
Skip to footer
Home
News Channels
Antibodies
Proteins and Peptides
Vaccines
DNA RNA and Cells
Small Molecules
More News
All News
Reports
Press Room
Contact Us
About Us
All Categories
Antibodies
DNA RNA and Cells
More News
Proteins and Peptides
Small Molecules
Vaccines
Any Word
All Words
Exact Phrase
Immuno-Oncology
Aug 2024
CD47 and SIRP-alpha Targeted Immunotherapy Pipeline Review
400,00€
Mar 2024
CD38-Targeted Antibody & Cell Therapy Pipeline Review
300,00€
Nov 2023
B7-H3-Targeted Immunotherapy Candidates Pipeline Review
300,00€
Sep 2023
CCR8-Targeted Antibody Immunotherapy Pipeline Review
300,00€
Aug 2023
CD40 Agonists & CD40/L Antagonists Pipeline Review
300,00€
May 2022
Claudin 6: A target opportunity to develop effector-enhanced drug modalities
500,00€
Oct 2021
Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective
2.250,00€
Jun 2019
Bispecific Antibodies for Immuno-Oncology & Other Diseases
800,00€
Jun 2019
Report Package: Bispecific Antibodies
3.150,00€
2.500,00€
Any Word
All Words
Exact Phrase
Report categories
Antibody & Protein Sales
Antibody Technologies
Biosimilar Antibodies & Proteins
CAR T-Cells
Drug the Undruggable Technologies
Immuno-Oncology
mRNA Vaccines & Therapeutics
NK Cells & CAR Macrophages
Pipeline Database
RNA-Targeted Therapeutics
Target Pipelines
TCR T-Cells and Antibodies
Therapeutic Antibodies
Therapeutic Proteins & Peptides
